Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eton Pharmaceutcials Inc
(NQ:
ETON
)
3.060
-0.080 (-2.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
68,832
Open
3.110
Bid (Size)
3.060 (4)
Ask (Size)
3.150 (1)
Prev. Close
3.140
Today's Range
3.060 - 3.200
52wk Range
2.420 - 5.810
Shares Outstanding
25,688,062
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via
Benzinga
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
March 22, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Performance
YTD
-33.33%
-33.33%
1 Month
-13.56%
-13.56%
3 Month
-25.00%
-25.00%
6 Month
-18.83%
-18.83%
1 Year
-16.16%
-16.16%
More News
Read More
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 14, 2024
Via
InvestorPlace
Recap: Eton Pharmaceuticals Q4 Earnings
March 14, 2024
Via
Benzinga
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Earnings Preview
March 13, 2024
Via
Benzinga
Is NASDAQ:ETON suited for growth investing?
March 06, 2024
Via
Chartmill
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
Why the growth investor may take a look at NASDAQ:ETON.
February 14, 2024
Via
Chartmill
Evaluating NASDAQ:ETON for Growth Investment Opportunities.
January 22, 2024
Via
Chartmill
Eton Pharmaceuticals: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
February 29, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
February 21, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
February 02, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Eton Pharmaceuticals
Via
GlobeNewswire
Gilead Sciences Tops Q3 Earnings And Revenue Estimates
November 07, 2023
Via
Talk Markets
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
October 30, 2023
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
October 04, 2023
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 23, 2023
From
Eton Pharmaceuticals
Via
GlobeNewswire
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 11, 2023
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Friday's Intraday Session
August 11, 2023
Via
Benzinga
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
August 11, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FSR Stock Alert: What to Know About the New Fisker Ronin EV
August 11, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 11, 2023
Via
Benzinga
Why Is Cano Health (CANO) Stock Down 48% Today?
August 11, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.